• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝裂霉素C对临床分离的产志贺毒素大肠杆菌诱导产志贺毒素的影响。

The Effect of Mitomycin C on Induction of Shiga Toxin Production in Clinical STEC Isolates.

作者信息

Thilakarathna Surangi H, Parsons Brendon, Chui Linda

机构信息

Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 1C9, Canada.

Alberta Precision Laboratories-Public Health Laboratory (ProvLab), Edmonton, AB T6G 2J2, Canada.

出版信息

Toxins (Basel). 2025 May 27;17(6):267. doi: 10.3390/toxins17060267.

DOI:10.3390/toxins17060267
PMID:40559845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12197360/
Abstract

Early determination of the Shiga toxin type of Shiga toxin-producing (STEC) is crucial for guiding STEC-infected patients for proper and timely treatment and patient care. Most diagnostic microbiology laboratories rely on PCR assays to detect the presence of and/or and enzymatic immunoassays (EIA) to detect the presence of the Shiga toxins 1 and/or 2 in STEC-positive stool samples. Occasionally, the stool samples test positive for STEC by PCR assays but test negative for the presence of Shiga toxins. Insufficient toxin production under laboratory conditions is the main culprit of this discordance. To test whether EIA-based STEC detection could be improved, various clinical STEC strains were treated with mitomycin C, which is a commonly used inducer of Shiga toxin production. A dose-dependent increase in Shiga toxin production, in response to mitomycin C doses of up to 500 ng/mL, was observed without any bactericidal effects. Depending on the serotype, 5-50 times more Shiga toxin 2 was produced than Shiga toxin 1. Shiga toxin production was not induced by the mitomycin C treatment in certain STEC serotypes carrying the toxin subtypes , , , , . This diversity in toxin production indicates that other factors may determine toxin expression in certain STEC strains, which warrant further exploration.

摘要

早期确定产志贺毒素大肠杆菌(STEC)的志贺毒素类型对于指导STEC感染患者进行恰当且及时的治疗及护理至关重要。大多数诊断微生物实验室依靠聚合酶链反应(PCR)检测来确定是否存在 及/或 ,并通过酶免疫测定(EIA)来检测STEC阳性粪便样本中志贺毒素1和/或2的存在情况。偶尔,粪便样本通过PCR检测呈STEC阳性,但志贺毒素检测呈阴性。实验室条件下毒素产生不足是这种不一致的主要原因。为了测试基于EIA的STEC检测是否可以改进,用丝裂霉素C处理了各种临床STEC菌株,丝裂霉素C是一种常用的志贺毒素产生诱导剂。观察到随着丝裂霉素C剂量增加至500 ng/mL,志贺毒素产量呈剂量依赖性增加,且没有任何杀菌作用。根据血清型,志贺毒素2的产量比志贺毒素1多5至50倍。在携带毒素亚型 、 、 、 、 的某些STEC血清型中,丝裂霉素C处理未诱导志贺毒素产生。毒素产生的这种多样性表明,其他因素可能决定某些STEC菌株中的毒素表达,这值得进一步探索。

相似文献

1
The Effect of Mitomycin C on Induction of Shiga Toxin Production in Clinical STEC Isolates.丝裂霉素C对临床分离的产志贺毒素大肠杆菌诱导产志贺毒素的影响。
Toxins (Basel). 2025 May 27;17(6):267. doi: 10.3390/toxins17060267.
2
Differential induction of Shiga toxin in environmental Escherichia coli O145:H28 strains carrying the same genotype as the outbreak strains.具有与暴发菌株相同基因型的环境大肠杆菌 O145:H28 菌株中志贺毒素的差异诱导。
Int J Food Microbiol. 2021 Feb 2;339:109029. doi: 10.1016/j.ijfoodmicro.2020.109029. Epub 2020 Dec 23.
3
Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.溶血尿毒综合征相关和牛源产志贺毒素大肠杆菌分离株产志贺毒素的比较。
Appl Environ Microbiol. 2003 Feb;69(2):1059-66. doi: 10.1128/AEM.69.2.1059-1066.2003.
4
Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic review.产志贺毒素大肠埃希菌溶血尿毒综合征应用依库珠单抗治疗:系统评价。
Pediatr Nephrol. 2024 May;39(5):1369-1385. doi: 10.1007/s00467-023-06216-1. Epub 2023 Dec 6.
5
Virulence genes, Shiga toxin subtypes, major O-serogroups, and phylogenetic background of Shiga toxin-producing Escherichia coli strains isolated from cattle in Iran.从伊朗牛群中分离出的产志贺毒素大肠杆菌菌株的毒力基因、志贺毒素亚型、主要O血清群及系统发育背景
Microb Pathog. 2017 Aug;109:274-279. doi: 10.1016/j.micpath.2017.05.041. Epub 2017 May 31.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Real-Time PCR Assay for Detection and Differentiation of Shiga Toxin-Producing Escherichia coli from Clinical Samples.用于从临床样本中检测和区分产志贺毒素大肠杆菌的实时聚合酶链反应检测法
J Clin Microbiol. 2015 Jul;53(7):2148-53. doi: 10.1128/JCM.00115-15. Epub 2015 Apr 29.
8
Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples.评估ProSpecT志贺毒素大肠杆菌微孔板检测法在粪便样本中检测产志贺毒素大肠杆菌的性能及潜在临床影响。
J Clin Microbiol. 2004 Apr;42(4):1652-6. doi: 10.1128/JCM.42.4.1652-1656.2004.
9
Comparable stx expression and phage production levels between Shiga toxin-producing Escherichia coli strains from human and bovine origin.人源和牛源产志贺毒素大肠杆菌菌株之间stx 表达和噬菌体产生水平相当。
Zoonoses Public Health. 2020 Feb;67(1):44-53. doi: 10.1111/zph.12653. Epub 2019 Dec 23.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.

本文引用的文献

1
Shiga Toxin-Producing and the Hemolytic-Uremic Syndrome.产志贺毒素与溶血尿毒综合征
N Engl J Med. 2023 Oct 12;389(15):1402-1414. doi: 10.1056/NEJMra2108739.
2
Pathogenomes and variations in Shiga toxin production among geographically distinct clones of O113:H21.地理上不同克隆株 O113:H21 中志贺毒素产生的病原体基因组和变异。
Microb Genom. 2022 Apr;8(4). doi: 10.1099/mgen.0.000796.
3
Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections.为什么抗生素不应被用于治疗产志贺毒素大肠杆菌感染。
Curr Opin Gastroenterol. 2022 Jan 1;38(1):30-38. doi: 10.1097/MOG.0000000000000798.
4
Comparison of Common Enrichment Broths Used in Diagnostic Laboratories for Shiga Toxin-Producing .诊断实验室用于产志贺毒素菌的常见增菌肉汤的比较
Microorganisms. 2021 Feb 27;9(3):503. doi: 10.3390/microorganisms9030503.
5
Effects of antimicrobials on Shiga toxin production in high-virulent Shiga toxin-producing Escherichia coli.抗菌药物对产高毒力志贺毒素大肠杆菌产志贺毒素的影响。
Microb Pathog. 2021 Mar;152:104636. doi: 10.1016/j.micpath.2020.104636. Epub 2020 Nov 24.
6
Efficiency of induction of Shiga-toxin lambdoid prophages in Escherichia coli due to oxidative and antibiotic stress depends on the combination of prophage and the bacterial strain.由于氧化应激和抗生素应激,大肠杆菌中志贺毒素样原噬菌体的诱导效率取决于原噬菌体和细菌菌株的组合。
J Appl Genet. 2020 Feb;61(1):131-140. doi: 10.1007/s13353-019-00525-8. Epub 2019 Dec 6.
7
CPHLN recommendations for the laboratory detection of Shiga toxin-producing (O157 and non-O157).加拿大公共卫生实验室网络关于产志贺毒素(O157和非O157)实验室检测的建议。
Can Commun Dis Rep. 2018 Nov 1;44(11):304-307. doi: 10.14745/ccdr.v44i11a06.
8
Factors in the emergence of serious human infections associated with highly pathogenic strains of shiga toxin-producing Escherichia coli.产志贺毒素大肠埃希氏菌高致病性株引起的严重人类感染的出现因素。
Int J Med Microbiol. 2018 Dec;308(8):1067-1072. doi: 10.1016/j.ijmm.2018.08.005. Epub 2018 Aug 19.
9
A Rapid Immunoassay for Detection of Shiga Toxin-Producing Escherichia coli Directly from Human Fecal Samples and Its Performance in Detection of Toxin Subtypes.一种直接从人类粪便样本中检测产志贺毒素大肠杆菌的快速免疫测定法及其在毒素亚型检测中的性能。
J Clin Microbiol. 2016 Dec;54(12):3056-3063. doi: 10.1128/JCM.01785-16. Epub 2016 Oct 12.
10
Detection, Characterization, and Typing of Shiga Toxin-Producing Escherichia coli.产志贺毒素大肠杆菌的检测、特性鉴定及分型
Front Microbiol. 2016 Apr 12;7:478. doi: 10.3389/fmicb.2016.00478. eCollection 2016.